##gff-version 3
P51480	UniProtKB	Chain	1	168	.	.	.	ID=PRO_0000144178;Note=Cyclin-dependent kinase inhibitor 2A	
P51480	UniProtKB	Repeat	3	32	.	.	.	Note=ANK 1	
P51480	UniProtKB	Repeat	36	64	.	.	.	Note=ANK 2	
P51480	UniProtKB	Repeat	69	98	.	.	.	Note=ANK 3	
P51480	UniProtKB	Repeat	102	131	.	.	.	Note=ANK 4	
P51480	UniProtKB	Region	148	168	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P51480	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P42771	
P51480	UniProtKB	Modified residue	164	164	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P42771	
P51480	UniProtKB	Alternative sequence	1	43	.	.	.	ID=VSP_015867;Note=In isoform 2. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51480	UniProtKB	Natural variant	12	12	.	.	.	Note=In some liver tumors. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9667743;Dbxref=PMID:9667743	
P51480	UniProtKB	Natural variant	18	18	.	.	.	Note=In strain: 020%2C BALB/c%2C BALB/cJ%2C C3H/21BG%2C C3H/HeJ%2C CBA/J%2C MA/M4J and PL/J. H->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9021155,ECO:0000269|PubMed:9482902,ECO:0000269|Ref.7;Dbxref=PMID:9021155,PMID:9482902	
P51480	UniProtKB	Natural variant	27	27	.	.	.	Note=In some liver tumors. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9667743;Dbxref=PMID:9667743	
P51480	UniProtKB	Natural variant	51	51	.	.	.	Note=In strain: BALB/c and BALB/cJ. V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9482902,ECO:0000269|Ref.7;Dbxref=PMID:9482902	
P51480	UniProtKB	Natural variant	73	73	.	.	.	Note=In some liver tumors. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9667743;Dbxref=PMID:9667743	
P51480	UniProtKB	Natural variant	74	74	.	.	.	Note=In plasmacytoma cell lines. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9482902;Dbxref=PMID:9482902	
P51480	UniProtKB	Natural variant	75	75	.	.	.	Note=In plasmacytoma cell lines. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9482902;Dbxref=PMID:9482902	
P51480	UniProtKB	Natural variant	90	90	.	.	.	Note=In strain: BALB/cJ%2C C57BL/6J and MOLF/Ei. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
P51480	UniProtKB	Natural variant	90	90	.	.	.	Note=In plasmacytoma cell lines. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9482902;Dbxref=PMID:9482902	
P51480	UniProtKB	Natural variant	127	127	.	.	.	Note=In strain: BALB/cJ%2C C57BL/6J and MOLF/Ei. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
P51480	UniProtKB	Mutagenesis	64	64	.	.	.	Note=No effect on activity. C->G%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9012842;Dbxref=PMID:9012842	
P51480	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss of activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9012842;Dbxref=PMID:9012842	
P51480	UniProtKB	Mutagenesis	84	85	.	.	.	Note=Loss of activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9012842;Dbxref=PMID:9012842	
P51480	UniProtKB	Sequence conflict	11	11	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305